Miquel Nolla-Salas | Fungal Infections and Challenges in Treatment | Best Researcher Award

Posted on by Infectious

Best Researcher Award

Miquel Nolla-Salas
Unió-Consorci-Formació, Spain

Miquel Nolla-Salas
Affiliation Unió-Consorci-Formació
Country Spain
Scopus ID 6701580090
Documents 32
Citations 159
h-index 5
Subject Area Fungal Infections and Challenges in Treatment
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-8765-5506

The Best Researcher Award recognition highlights the scholarly contributions of Miquel Nolla-Salas in the field of infectious diseases, with particular emphasis on fungal infections, candidiasis, intensive care medicine, and treatment challenges. Through research, supervision, clinical investigations, and scientific dissemination, the researcher has contributed to the advancement of evidence-based approaches that support improved understanding of opportunistic fungal diseases and their management in healthcare settings.[1]

Abstract

Miquel Nolla-Salas has developed an academic and clinical research profile focused on infectious diseases, critical care medicine, and fungal infections. His scientific work has addressed the epidemiology, diagnosis, prevention, and treatment of candidiasis and related opportunistic infections among hospitalized and critically ill patients. Through peer-reviewed publications, postgraduate supervision, and collaborative investigations, he has contributed to the generation of clinical evidence supporting therapeutic decision-making and improved patient management. His scholarly record demonstrates sustained engagement with infection control challenges and the advancement of medical knowledge relevant to healthcare professionals, researchers, and clinical institutions worldwide.[1][2]

Keywords

Fungal Infections, Candidiasis, Infectious Diseases, Intensive Care Medicine, Clinical Research, Antifungal Therapy, Epidemiology, Critical Care, Medical Education, Healthcare Outcomes.

Introduction

Research concerning fungal infections remains a significant component of infectious disease management due to increasing healthcare complexity and vulnerable patient populations. Miquel Nolla-Salas has participated in investigations examining infection prevalence, diagnostic methodologies, and therapeutic interventions that seek to reduce morbidity and improve treatment effectiveness in clinical environments.[2]

Research Profile

The researcher’s academic profile reflects interdisciplinary engagement across infectious diseases, intensive care medicine, and fungal pathogen management. His publication portfolio includes studies addressing candidiasis prevalence, therapeutic evaluation, and infection-related outcomes. Academic activities have additionally included postgraduate mentorship and thesis supervision, supporting the development of future researchers and healthcare professionals.[1][3]

Research Contributions

His research contributions have focused on improving understanding of invasive fungal infections, especially among critically ill patients. Investigations have explored disease identification, risk assessment, therapeutic strategies, and evidence-based clinical management. These contributions have supported broader discussions regarding early diagnosis and optimized antifungal interventions within healthcare systems.[2][4]

Publications

The researcher’s publication record consists of peer-reviewed scientific articles indexed within recognized scholarly databases. These publications address clinically relevant topics associated with infectious diseases and fungal treatment challenges. Citation metrics indicate continuing scholarly visibility and engagement within the scientific community.[1]

Research Impact

Research impact can be evaluated through publication output, citation activity, academic mentorship, and contributions to clinical practice discussions. The documented citation record reflects scholarly engagement with his findings. Furthermore, the translation of research knowledge into clinical contexts demonstrates relevance to healthcare improvement and infectious disease management initiatives.[1][5]

Award Suitability

Miquel Nolla-Salas demonstrates several characteristics commonly associated with recipients of research recognition awards. These include a sustained publication record, measurable citation performance, active participation in scholarly research, contributions to postgraduate supervision, and commitment to advancing knowledge related to fungal infections and treatment challenges. Such achievements align with the objectives of the International Research Awards on Infectious Diseases, which recognize impactful and evidence-based scientific contributions.[1][3]

Conclusion

The academic profile of Miquel Nolla-Salas reflects a career dedicated to addressing significant challenges in infectious diseases and fungal infection management. His scholarly activities, publication contributions, mentorship roles, and clinical research involvement collectively support recognition within the international research community. The body of work demonstrates ongoing relevance to healthcare practice, scientific advancement, and future investigations in infectious disease research.[1][4]

References

  1. Elsevier. (n.d.). Scopus author details: Miquel Nolla-Salas, Author ID 6701580090. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701580090
  2. Miquel Nolla-Salas; Jordi Ibañez-Nolla. Candida in the ICU, Risk Management and Patient Safety.
    https://doi.org/10.3390/microorganisms14061200
  3. ORCID. (n.d.). Research profile of Miquel Nolla-Salas.
    https://orcid.org/0000-0002-8765-5506
  4. International Journal of Infectious Diseases (2024). Multifocal candidiasis can be considered a form of invasive candidiasis in critically non-neutropenic patients.
    https://doi.org/10.1016/j.ijid.2024.107171
  5. International Research Awards on Infectious Diseases. Award recognition and evaluation framework.
    https://infectious-diseases-conferences.pencis.com/

Shuwen Han | Microbial Pathogenesis and Virulence | Best Researcher Award

Posted on by Infectious

Best Researcher Award

Shuwen Han
Tarim University, China

Shuwen Han
Affiliation Tarim University
Country China
Scopus ID 56089782700
Documents 117
Citations 2,323
h-index 27
Subject Area Microbial Pathogenesis and Virulence
Event International Research Awards on Infectious Diseases
ORCID 0000-0001-6180-9565

The Best Researcher Award recognizes distinguished scholarly achievement, sustained scientific productivity, and impactful contributions to infectious disease research. Shuwen Han of Tarim University has established a significant academic profile through extensive publication activity, citation performance, and research focused on microbial pathogenesis, host–pathogen interactions, and virulence mechanisms. The researcher’s documented output and influence within microbiology and infectious disease studies provide a basis for evaluating suitability for recognition within the International Research Awards on Infectious Diseases.[1]

Abstract

Shuwen Han is an academic researcher affiliated with Tarim University whose scholarly work primarily addresses microbial pathogenesis, bacterial virulence, infectious disease mechanisms, and host–microbe interactions. With more than one hundred indexed publications and over two thousand citations, the researcher has contributed to the advancement of microbiological knowledge through experimental investigations and collaborative studies. The documented research portfolio demonstrates consistent scientific productivity, international visibility, and measurable influence within the infectious disease community. These achievements support consideration for the Best Researcher Award at the International Research Awards on Infectious Diseases and reflect sustained commitment to scientific excellence and knowledge dissemination.[1][2]

Keywords

Microbial Pathogenesis, Virulence Factors, Infectious Diseases, Microbiology, Host–Pathogen Interactions, Scientific Impact, Citation Analysis, Research Excellence.

Introduction

Research in infectious diseases remains essential for understanding pathogen biology, disease transmission, and public health challenges. Scientists working in microbial pathogenesis contribute valuable evidence for improving diagnostics, prevention strategies, and therapeutic interventions. Within this context, Shuwen Han has developed a research portfolio emphasizing mechanisms of bacterial virulence and microbial behavior, generating findings that support broader scientific understanding and future biomedical applications.[2]

Research Profile

The research profile of Shuwen Han reflects sustained academic productivity and recognized scientific influence. Indexed publication records indicate extensive engagement in microbiology and infectious disease research. Citation metrics and h-index values suggest that published findings have been referenced by researchers across related disciplines, demonstrating both visibility and scholarly relevance within the scientific literature.[1]

Research Contributions

Shuwen Han has contributed to investigations involving bacterial pathogenicity, virulence determinants, microbial adaptation, and disease-related biological processes. The research outputs support a deeper understanding of how microorganisms interact with hosts and environmental conditions. Such contributions are relevant to ongoing efforts aimed at improving infectious disease management, microbial surveillance, and translational microbiological research.[3]

Publications

The publication portfolio includes peer-reviewed articles addressing microbial pathogenesis, bacterial virulence mechanisms, infection biology, and related microbiological themes. Research outputs have appeared in recognized scientific journals and have contributed to scholarly discussions concerning pathogen behavior and disease development. The breadth of publications demonstrates ongoing participation in advancing infectious disease knowledge through evidence-based investigation.[2][4]

  • Microbial pathogenesis studies.
  • Virulence-related investigations.
  • Host–pathogen interaction research.
  • Infectious disease microbiology publications.

Research Impact

Research impact may be assessed through publication productivity, citation performance, and influence on subsequent scientific studies. With more than 2,300 citations and an h-index of 27, Shuwen Han demonstrates measurable academic impact. These indicators suggest that the researcher’s findings have contributed to ongoing scientific dialogue and have informed further investigations in microbiology and infectious diseases.[1]

Award Suitability

Evaluation for the Best Researcher Award typically considers originality, publication record, citation influence, disciplinary relevance, and contributions to scientific advancement. Based on available scholarly indicators, Shuwen Han demonstrates qualifications aligned with these criteria. The combination of extensive research output, recognized citation performance, and specialization in infectious disease-related microbiology supports consideration for academic recognition within an international award framework.[1][5]

Conclusion

Shuwen Han has established a notable research profile characterized by consistent publication activity, significant citation performance, and contributions to microbial pathogenesis and virulence research. The documented scholarly achievements reflect sustained engagement in advancing infectious disease knowledge. Based on academic metrics and research relevance, the researcher presents a strong case for consideration within the Best Researcher Award category of the International Research Awards on Infectious Diseases.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Shuwen Han, Author ID 56089782700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56089782700
  2. ORCID. (n.d.). ORCID profile of Shuwen Han.
    https://orcid.org/0000-0001-6180-9565
  3. Future Microbiology. (2022). Bacterial imaging in tumour diagnosis.
    https://doi.org/10.1111/1751-7915.14474
  4. Journal of Translational Medicine. (2025). Dissolving microneedles enabled delivery of Oxaliplatin- sodium butyrate loaded outer membrane vesicles against rectal cancer.
    https://doi.org/10.1186/s12967-025-06921-5
  5. International Research Awards on Infectious Diseases. (n.d.). Award criteria and evaluation guidelines.
    https://infectious-diseases-conferences.pencis.com/

Janet Nale | Microbial Pathogenesis | Innovative Research Award

Posted on by Infectious

Innovative Research Award

Janet Nale
Affiliation Scotland’s Rural College
Country United Kingdom
Scopus ID 55247908300
Documents 25
Citations 821
h-index 13
Subject Area Microbial Pathogenesis
Event International Research Awards on Infectious Diseases
ORCID
0000-0003-0501-7402
Janet Nale
Scotland’s Rural College, United Kingdom

The Innovative Research Award recognizes notable scholarly contributions in the field of microbial pathogenesis and infectious disease research. Janet Nale, affiliated with Scotland’s Rural College in the United Kingdom, has established a recognized academic profile through interdisciplinary research focused on microbial interactions, bacteriophage applications, and pathogenic mechanisms associated with infectious diseases.[1] The researcher has contributed to peer-reviewed scientific literature indexed within major international databases and has demonstrated measurable research impact through citations and collaborative scientific output.[2]

Abstract

This academic profile summarizes the scholarly achievements and scientific contributions of Janet Nale within the discipline of microbial pathogenesis and infectious disease research. The profile highlights research productivity, citation metrics, peer-reviewed publications, and interdisciplinary investigations relevant to microbial interactions and bacteriophage-mediated therapeutic strategies.[2] The documented academic impact reflects sustained engagement in scientific inquiry associated with pathogen control, antimicrobial alternatives, and microbiological innovation within agricultural and biomedical contexts.[3]

Keywords

Microbial Pathogenesis, Infectious Diseases, Bacteriophage Therapy, Antimicrobial Resistance, Veterinary Microbiology, Pathogen Control, Scientific Innovation, Academic Research Impact

Introduction

Research concerning microbial pathogenesis remains a central component of global infectious disease investigations due to the increasing prevalence of antimicrobial resistance and emerging pathogenic threats.[4] Janet Nale has contributed to this field through research associated with bacteriophage biology, pathogen-host interactions, and microbial ecology. The academic contributions linked with Scotland’s Rural College demonstrate engagement in applied microbiological studies with relevance to both veterinary and public health domains.[5]

Research Profile

Janet Nale is associated with Scotland’s Rural College in the United Kingdom and maintains a documented scholarly presence within international indexing platforms including Scopus and ORCID.[1] The research profile includes 25 indexed documents, 821 citations, and an h-index of 13, reflecting measurable academic engagement and citation visibility within microbial sciences.[2]

Research Contributions

The research contributions associated with Janet Nale include studies on bacteriophage characterization, antimicrobial alternatives, and pathogen management strategies. Scientific investigations have explored bacteriophage-host interactions relevant to the control of infectious bacterial populations and the mitigation of antimicrobial resistance concerns.[7]

Publications

Selected publications attributed to Janet Nale include studies concerning bacteriophage applications, microbial pathogen analysis, and therapeutic microbiology. These publications have appeared in peer-reviewed scientific journals focused on microbiology, infectious diseases, and microbial pathogenesis.[7]

  1. Research involving bacteriophage-mediated control of pathogenic bacteria and antimicrobial-resistant organisms.[7]
  2. Studies examining microbiological interactions relevant to infectious disease transmission and prevention.[8]

Research Impact

The research impact of Janet Nale is reflected through citation metrics, indexed scholarly publications, and interdisciplinary collaborations documented within academic databases.[2] An h-index of 13 indicates a consistent level of citation engagement across multiple publications, while the citation count of 821 demonstrates the relevance of the researcher’s work within microbial pathogenesis and infectious disease studies.[1]

Award Suitability

The documented academic profile of Janet Nale demonstrates suitability for recognition within the International Research Awards on Infectious Diseases due to sustained scholarly activity, citation impact, and subject specialization in microbial pathogenesis.[3] The combination of indexed publications, interdisciplinary scientific collaborations, and contributions to bacteriophage research supports the significance of the researcher’s work within contemporary infectious disease studies.[7]

Conclusion

Janet Nale has developed an established academic profile through contributions to microbial pathogenesis and infectious disease research. The researcher’s publication record, citation metrics, and scientific investigations demonstrate engagement with contemporary microbiological challenges associated with pathogen control and antimicrobial resistance.[2] The overall scholarly profile reflects sustained scientific productivity and interdisciplinary research relevance suitable for academic recognition within international infectious disease award programs.

References

  1. Elsevier. (n.d.). Scopus author details: Janet Nale, Author ID 55247908300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55247908300
  2. ORCID. (n.d.). Janet Nale: ORCID researcher profile.
    https://orcid.org/0000-0003-0501-7402
  3. Nale, J. Y., Redgwell, T. A., Millard, A., & Clokie, M. R. J. (n.d.). Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.
    https://pubmed.ncbi.nlm.nih.gov/29438355/
  4. Nale, J. Y., Shan, J., Hickenbotham, P. T., Fawley, W. N., Wilcox, M. H., & Clokie, M. R. J. (n.d.). Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains.
    https://pubmed.ncbi.nlm.nih.gov/22624004/
  5. Nale, J. Y., Spencer, J., Hargreaves, K. R., Buckley, A. M., Trzepiński, P., & Douce, G. R. (n.d.). Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
    https://pubmed.ncbi.nlm.nih.gov/26643348/

Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award 

Professor | UCLA | United States

Dr. Yvonne L. Hernandez-Kapila is a distinguished clinician-scientist, academic leader, and global research contributor recognized for her transformative work in oral biology, periodontology, and cancer biology. As Professor and Associate Dean for Research at the UCLA School of Dentistry and the Felix and Mildred Yip Endowed Chair in Dentistry, her research has significantly advanced understanding of the molecular and cellular mechanisms underlying periodontal disease, oral cancer, and host-microbiome interactions. Her laboratory’s pioneering investigations into the oral-gut-brain axis, bacteriocin therapeutics, and oral virome have shaped new paradigms in microbial pathogenesis, inflammation, and regenerative oral health. A prolific author with more than a hundred peer-reviewed publications in leading journals such as NPJ Biofilms and Microbiomes, Journal of Biological Chemistry, PLOS Pathogens, and Cell Death and Differentiation, Dr. Kapila’s work bridges fundamental discovery with translational innovation. She has served as principal investigator on multiple NIH-funded projects, including major initiatives exploring host–bacterial dynamics and microbiome modulation in oral and systemic disease contexts. Her editorial leadership extends across several international journals and major textbooks, including Periodontology 2000 and Newman and Carranza’s Clinical Periodontology, where she continues to shape scholarly discourse in the field. Dr. Kapila has received numerous prestigious honors recognizing her scientific excellence, mentorship, and contributions to dental research, including awards from the American Dental Association, the American Academy of Periodontology, and the American Association for Dental Research. A dedicated mentor, she has guided over a hundred trainees and junior faculty toward successful academic and research careers worldwide, championing inclusivity, rigorous scientific methodology, and leadership development. Through her interdisciplinary collaborations and global initiatives, Dr. Kapila continues to influence the future of oral health sciences, biomolecular therapeutics, and translational medicine, establishing herself as a leading voice in advancing oral-systemic health research on an international scale. She has 8347 citations from 146 documents with an h-index of 47.

Profiles: Scopus | ORCID

Publications

1. B. lactis HN019 modulates periapical inflammation and enhances cementum repair by increasing CEMP-1 expression in an animal model. (2025). Archives of Oral Biology.

2. The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. (2025). Virology Journal.

3. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. (2024). NPJ Biofilms and Microbiomes.

4. Biological biomarkers of oral cancer. (2025). [Journal name not specified].

5. Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. (2024). Microorganisms.

Dr. Abeni Beshiru | Microbiology | Best Academic Researcher Award

Posted on by Infectious

Dr. Abeni Beshiru | Microbiology | Best Academic Researcher Award

Western Delta University | Nigeria.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Dr. Abeni Beshiru began her academic journey with a B.Sc. in Microbiology, laying the foundation for her fascination with microbial systems and public health. She pursued her postgraduate studies with a strong commitment to infectious diseases and foodborne pathogens, eventually earning her Ph.D. in Microbiology, where her thesis focused on the microbial quality of food and antimicrobial resistance—a subject that continues to define her research trajectory.

💼PROFESSIONAL ENDEAVORS

With a career marked by dedication and excellence, Dr. Beshiru has held numerous academic and research appointments. She has contributed to several university-based laboratories and national health initiatives, focusing on microbial risk assessments, environmental microbiology, and food safety research. Her interdisciplinary approach bridges microbiology with public health, making her an indispensable asset in both academic and clinical microbiology circles.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MICROBIOLOGY

Dr. Beshiru’s research spans critical areas in environmental and food microbiology, including antibiotic-resistant bacteria, foodborne pathogens, and the microbiological integrity of food processing environments. She has also explored the dynamics of microbial communities in response to environmental stressors. Her pioneering studies have shed light on Listeria monocytogenes, Salmonella spp., and multi-drug resistant enteric bacteria in consumer foods.

🌍IMPACT AND INFLUENCE

Dr. Beshiru’s work has had a global impact, influencing food safety policies and microbial risk assessment frameworks. Her publications have informed policy briefs and food regulatory standards, particularly in developing countries, where her research addresses pressing issues of sanitation, safe food handling, and emerging pathogens. She is often sought after as a consultant and collaborator in multinational projects.

🏆RESEARCH GRANTS AND FUNDING

Dr. Beshiru has been the recipient of competitive research grants, including funding from national research councils and international organizations supporting projects in foodborne disease surveillance, bacterial resistance profiling, and community-based microbial education. These grants underscore the trust and investment in her scientific leadership and innovation.

🦠LEGACY AND FUTURE CONTRIBUTIONS

She is committed to mentoring early-career researchers, encouraging innovation in microbiological diagnostics, and promoting data-driven approaches to public health microbiology. Her legacy includes student mentorship, laboratory capacity-building, and published toolkits for microbiological analysis. Her future goals focus on combating antimicrobial resistance through genomic surveillance and predictive modeling.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Abeni Beshiru stands out as a visionary leader in the field of infectious disease microbiology, particularly in the context of global health challenges. Her foresight, scientific acumen, and collaborative spirit position her as a key figure in shaping the next generation of microbial threat response strategies.

📑NOTABLE PUBLICATIONS

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Posted on by Infectious

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Auckland University of Technology | New Zealand.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Mr. Silas Adjei–Gyamfi began his academic journey with a profound interest in microbiology and infectious diseases, laying a strong foundation in biomedical science. His early studies were marked by academic excellence and scientific curiosity, leading him to pursue specialized training in pathogen biology, clinical microbiology, and molecular epidemiology.

💼PROFESSIONAL ENDEAVORS

Mr. Adjei–Gyamfi has consistently bridged the gap between theory and practice, applying his scientific expertise in a variety of clinical, research, and public health settings. His roles have included positions in academic laboratories, national health institutes, and international health organizations, where he has contributed to infectious disease diagnostics, control, and policy formulation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES

A core focus of Mr. Adjei–Gyamfi’s career has been on infectious disease surveillance, diagnostics, and prevention. His contributions span several critical areas:

  • Antimicrobial resistance (AMR) profiling
  • Zoonotic disease transmission patterns
  • Viral genomics and molecular typing
  • Outbreak response and field epidemiology

He is recognized for implementing innovative diagnostic technologies, such as real-time PCR, serological assays, and pathogen genome sequencing, to improve early detection and containment of outbreaks.

🌍IMPACT AND INFLUENCE

Mr. Adjei–Gyamfi’s research and leadership have directly influenced public health responses to infectious disease threats in sub-Saharan Africa and beyond. He has played instrumental roles in cross-border health initiatives, community-level disease education, and data-driven decision-making in epidemic control.

🏆RESEARCH GRANTS AND FUNDING

Mr. Adjei–Gyamfi has successfully secured competitive research funding from national and international agencies, including:

  • World Health Organization (WHO) initiatives
  • Global Fund-supported projects
  • National Institutes of Health (NIH) collaborations
  • Africa CDC and regional grants

These funds have supported capacity-building in diagnostics, community surveillance programs, and field research into infectious disease ecology.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Mr. Adjei–Gyamfi aims to build sustainable health research systems in low-resource settings. His future initiatives include:

  • Establishing infectious disease reference centers

  • Developing AI-driven surveillance platforms

  • Training young scientists in Africa in biosecurity and epidemiology

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Silas Adjei–Gyamfi embodies the spirit of innovation, resilience, and service in the infectious disease field. With a career marked by scientific integrity, collaborative leadership, and community-centered approaches, he continues to shape health outcomes at local and global levels.

📑NOTABLE PUBLICATIONS

Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

Authors: Adjei-Gyamfi, Silas; Asirifi, Abigail; Asobuno, Clotilda; Korang, Felix Kwame
Year: 2025
Journal: PLoS ONE

Risk factors for anaemia among pregnant women: A cross-sectional study in Upper East Region, Ghana

Authors: Asobuno, C.; Adjei-Gyamfi, S.; Aabebe, F.G.; Hammond, J.; Taikeophithoun, C.; Amunah, N.; Aoki, T.; Aiga, H.
Year: 2024
Journal: PLoS ONE​

Anaemia at 36 weeks of pregnancy: Prevalence and determinants among antenatal women attending peri-urban facilities in a developing country, Ghana

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Peprah, W.; Abbey, D.A.; Hamenoo, K.W.; Zakaria, M.S.; Mohammed, O.; Aryee, P.A.
Year: 2024
Journal: PLOS Global Public Health

Maternal anaemia and polycythaemia during pregnancy and risk of inappropriate birthweight for gestational age babies: A retrospective cohort study in the northern belt of Ghana

Authors: Adjei-Gyamfi, S.; Zakaria, M.S.; Asirifi, A.; Sulley, I.; Ibrahim, M.A.; Aryee, P.A.
Year: 2024
Journal: BMJ Open

Prevalence and associated risk factors of preterm and post-term births in Northern Ghana: A retrospective study in Savelugu Municipality

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Aiga, H.
Year: 2023
Journal: Journal of Pediatrics, Perinatology and Child Health

Mrs. Qi Wang | Microbiology | Best Researcher Award

Posted on by Infectious

Mrs. Qi Wang | Microbiology | Best Researcher Award

Shanxi university | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Mrs. Qi Wang began her distinguished academic journey at Shanxi University, China, where she demonstrated exceptional aptitude in the biological sciences. Her passion for exploring the unseen microbial world laid a solid foundation for her specialization in Microbiology, particularly in pathogenic organisms and infectious disease mechanisms. Her early academic success was marked by her commitment to both theoretical excellence and hands-on laboratory skills.

💼PROFESSIONAL ENDEAVORS

Following her academic accomplishments, Mrs. Wang embarked on a progressive career in research and academia, contributing to university-led programs, government-sponsored research, and international collaborations. Her professional roles have included lead microbiologist, research supervisor, and lecturer, where she has mentored countless emerging scientists and shaped microbiology curricula.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MICROBIOLOGY

Mrs. Wang’s research focuses on the molecular pathogenesis of infectious diseases, antibiotic resistance, and microbial genomics. Her cutting-edge studies have illuminated host-pathogen interactions, emerging microbial threats, and novel antimicrobial strategies. She is particularly known for her work on multidrug-resistant strains and novel diagnostic biomarkers, offering fresh insights into the global battle against infectious agents.

🌍IMPACT AND INFLUENCE

Mrs. Qi Wang’s work has had a far-reaching impact in the scientific community and beyond. Her findings have been pivotal in shaping public health strategies, influencing clinical microbiology protocols, and informing global antimicrobial policies. She is recognized for her interdisciplinary collaborations and her efforts to promote science-based healthcare decisions.

📚ACADEMIC CITATIONS

Her influential research is reflected in her impressive citation metrics across platforms like Google Scholar and ResearchGate. With numerous papers cited in top-tier microbiology and infectious disease journals, Mrs. Wang has become a trusted voice in the field, often referenced in systematic reviews, meta-analyses, and policy documents.

🏆RESEARCH GRANTS AND FUNDING

Mrs. Wang has secured multiple national and international grants, including funding from:

  • National Natural Science Foundation of China (NSFC)

  • Ministry of Education of the People’s Republic of China

  • Global Health Research Initiatives

Her projects have attracted competitive funding due to their innovation, clinical applicability, and potential for transformational outcomes in infectious disease management.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Mrs. Wang is committed to advancing precision microbiology, focusing on:

  • Personalized infectious disease treatment

  • Next-generation microbial diagnostics

  • Global surveillance systems for epidemic preparedness

She continues to mentor doctoral and postdoctoral researchers, ensuring a lasting legacy of scientific excellence and human impact.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mrs. Qi Wang stands as a visionary leader in the field of infectious diseases, driven by an unwavering commitment to scientific discovery, clinical relevance, and global health equity. Her work exemplifies the synergy of innovation and compassion, embodying the values of a true academic pioneer.

📑NOTABLE PUBLICATIONS

Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice

Authors: Qi Wang, Jiaqin Liu, Wenjun Qin, Jin Cai

Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Disorders of Consciousness: Mechanisms and Applications

Authors: Qi Wang, Jiawei Peng, Ye Tian, Jin Cai, Wenjun Qin
Journal: Current Microbiology
Publication Year: 2025